When you think of cannabis treatment, the first compounds that come to mind are THC (tetrahydrocannabinol) and CBD (cannabidiol). With both research and development excelling for both, researchers have discovered other less-known compounds that have significant health benefits. Medicinal cannabis drug development company Bod Australia Ltd (ASX: BOD) has successfully completed a proof of concept
Read More
With just four months of operating cash in the bank according to last month’s quarterly report, cannabis company Creso Pharma (ASX: CPH) are back in the headlines inking deals with the latest collaborative agreement to potentially enter the Australian body care market via Dr Pickles. Key to the non-binding Heads of Agreement (HoA) signed is
Read More
The burgeoning arms of cannabis treatment have made their way to Ireland, with regulators easing restrictions which has increased the amount of qualified retailers. Currently, there is a limited number of cannabis retailers in the Republic of Ireland. Today, Althea Group Holdings (ASX: AGH) has been granted a rare opportunity to enter the Irish cannabis
Read More
Australian medical cannabis company Little Green Pharma (ASX: LGP) has reached a major offtake agreement with Demecan to distribute cannabis products across Germany. With the German medical cannabis market estimated to be worth €7.7bn (A$11.2bn) by 2028, this opportunity marks a massive milestone for the Company. In July 2021, LGP acquired a world-class cultivation site
Read More
The ever progressive Canadians just know how to have fun which is just one reason cannabis-infused beverages are proving a major hit in the Great White North. Seeking to capitalising on this trend is medicines and recreational cannabis company Althea (ASX: AGH) which has partnered with beer giant The Boston Beer Company (NYSE: SAM) to
Read More
Touted as a miracle cure for just about any ailment, medicinal cannabis has been an interesting point of contention in healthcare for years now. The media hype around the stuff has increased, patient demand has increased, and global production is booming (legally). Canadian based Wolf Island Cannabis is currently constructing a cannabis cultivation facility in
Read More